findmyKOL
Clinical trialNCT05647122Active, not recruitingPhase 1Interventional

First in Human Study of AZD9592 in Solid Tumors

SponsorAstraZenecaEnrollment167Advanced Solid TumoursCarcinoma Non-small Cell LungColorectal NeoplasmsHead and Neck Neoplasms
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

46 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Research Site

    Kogarah, Australia

  • Research Site

    Melbourne, Australia

Canada
  • Research Site

    Edmonton, Alberta, Canada

  • Research Site

    Toronto, Ontario, Canada

China
  • Research Site

    Beijing, China

  • Research Site

    Chongqing, China

  • Research Site

    Guangzhou, China

  • Research Site

    Wuhan, China

France
  • Research Site

    Marseille, France

  • Research Site

    Rennes, France

  • Research Site

    Villejuif, France

Italy
  • Research Site

    Milan, Italy

  • Research Site

    Orbassano, Italy

  • Research Site

    Rozzano, Italy

  • Research Site

    Verona, Italy

Japan
  • Research Site

    Chūōku, Japan

  • Research Site

    Kashiwa, Japan

  • Research Site

    Kōtoku, Japan

Malaysia
  • Research Site

    Kuala Lumpur, Malaysia

  • Research Site

    Kuching, Malaysia

South Korea
  • Research Site

    Seoul, South Korea

  • Research Site

    Seoul, South Korea

  • Research Site

    Seoul, South Korea

  • Research Site

    Seoul, South Korea

Spain
  • Research Site

    Barcelona, Spain

  • Research Site

    Madrid, Spain

  • Research Site

    Seville, Spain

Taiwan
  • Research Site

    Taichung, Taiwan

  • Research Site

    Taipei, Taiwan

  • Research Site

    Taipei, Taiwan

  • Research Site

    Taoyuan, Taiwan

United States
  • Research Site

    Duarte, California, United States

  • Research Site

    North Haven, Connecticut, United States

  • Research Site

    Washington D.C., District of Columbia, United States

  • Research Site

    Chicago, Illinois, United States

  • Research Site

    Baltimore, Maryland, United States

  • Research Site

    Baltimore, Maryland, United States

  • Research Site

    Milford, Massachusetts, United States

  • Research Site

    Mineola, New York, United States

  • Research Site

    New York, New York, United States

6 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Dec 2022
Primary completion
3 Aug 2028
Completion
3 Aug 2028
Last update posted
11 Jun 2026
Registered enrollment
167
Registry id
NCT05647122

Cross-registrations

EU-CTR / CTIS (EudraCT)2022-501570-18-00

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.